UTHR
United Therapeutics·NASDAQ
--
--(--)
--
--(--)
8.01 / 10
Outperform
Analyst coverage is overwhelmingly bullish (Strong Buy at 100% from 1 provider), and fund flow evaluation is strong at 7.91/10, with positive trends in block and extra-large inflows despite negative small/medium flows. This combination suggests institutional confidence and sustained buying pressure, complementing the positive analyst stance.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-06
InstitutionUBS
Times predicted6
Historical Win Rate83.3%
What is the analyst consensus for UTHR?
- UTHR holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.01/10 (Outperform).
